News
H4: A Pragmatic Hub for Health and Care Innovation
In a world where the challenges of the health and care sectors are multiplying, H4 positions itself as a unique innovation hub in Lausanne, Switzerland. Through its pragmatic and collaborative approach, H4 supports groundbreaking projects and accelerates the development of impactful and sustainable solutions. Since its creation in 2022, with the support of the Fondation…
Read MoreHAYA Therapeutics Raises $65 Million in Series A Funding
The Series A round is led by Sofinnova Partners and Earlybird Venture Capital with syndicate including Eli Lilly and Company. The funding will help advance clinical development of heart failure lead candidate and expand platform targeting the regulatory genome. HAYA Therapeutics, SA, a biotechnology company pioneering precision RNA-guided regulatory genome targeting therapeutics that reprogram…
Read MoreCarewell Wins the 2025 PERL Trophy
The 23rd edition of the Prix Entreprendre Lausanne Région (PERL) took place on Wednesday 7 May, at Beaulieu-Lausanne, gathering around 300 leaders from politics, business, and academia. The prestigious Lausanne Région Trophy, worth CHF 50,000, was awarded to Carewell, a company based in Pully, for its innovative project at the intersection of technology and social…
Read MoreSwiss Medical Network joins the Mayo Clinic Care Network
Swiss Medical Network (Vaud – Switzerland) and Mayo Clinic are proud to announce that seven clinics and centres of Swiss Medical Network have joined the Mayo Clinic Care Network, becoming the first healthcare provider in Western Europe to enter the collaboration. The agreement includes Clinique de Genolier, Privatklinik Bethanien in Zurich, Clinica Sant’Anna in Lugano…
Read MoreSwiss Biotech Sector Shows Strength and Growth in 2024
Despite a challenging global market environment, the Swiss biotech sector once again demonstrated strength and resilience in 2024, as detailed in the newly released 2025 Swiss Biotech Report presented on 5 May 2025 during the Swiss Biotech Days. Co-authored by the Swiss Biotech Association, EY, and eight partner organizations, the report offers a deep dive…
Read MoreOncoSwab Secures CHF 1.3 Million Innosuisse Grant to Advance Lung Cancer Early Detection
OncoSwab, a Jura-based startup pioneering non-invasive cancer diagnostics, has secured a CHF 1.3 million Innosuisse grant to fund upcoming clinical trials in partnership with Inselspital Bern. The grant will enable OncoSwab to accelerate the clinical validation of its nasal fluid-based biomarker test — a revolutionary approach to the early detection of lung cancer. Addressing…
Read MoreMedical devices: Switzerland soon aligned with the FDA?
The Swiss government is working on a simplified validation procedure for medical devices that have already been authorised by the US FDA – involving private bodies in the assessment. During a session on 30 April 2025, the Federal Council has laid the groundwork for a wider supply of medical devices. The aim is…
Read MoreAktiia closes a CHF 34 million Series B and becomes Hilo
Aktiia, a blood pressure intelligence platform, announces an oversubscribed $42 million (over CHF 34 million) Series B funding round, co-led by Earlybird Health and Wellington Partners, with new investors Kfund and naturalX Health Ventures, and participation from existing investors redalpine, Khosla Ventures, Molten Ventures, Translink Capital and Verve Ventures. The investment, which has brought the total financing to…
Read MoreThree Geneva-based startups receive funding from the FONGIT Innovation Fund (FIF)
Three life sciences projects from Geneva have been awarded funding through the FONGIT Innovation Fund (FIF), underscoring the canton’s strong commitment to driving innovation and advancing sustainable solutions. CHF 100,000 FIF Seed Loan awarded to BrainScape Medical: Creating Solutions for Optimised Brain Health Management BrainScape Medical, a Geneva-based life sciences startup supported by…
Read MoreGESICA: Strengthening Cross-Border Health Crises Readiness
In an era marked by mounting pressure on healthcare systems and a growing number of exceptional public health emergencies, cross-border scientific collaboration has never been more critical. The GESICA project—GEstion des SItuations de Crises sAnitaires—is designed to address this challenge by enhancing the ability to detect, anticipate, and manage health crises across the France–Switzerland region.…
Read More